Recombinant Human Prostate Cancer Susceptibility Candidate (PRAC), Unconjugated

Product Overview

• Article Name: Recombinant Human Prostate Cancer Susceptibility Candidate (PRAC), Unconjugated
• Biozol Catalog Number: BIM-RPU58167
• Supplier Catalog Number: RPU58167
• Alternative Catalog Number: BIM-RPU58167-50UG, BIM-RPU58167-100UG, BIM-RPU58167-1MG
• Manufacturer: Biomatik Corporation
• Category: Proteine/Peptide
• Application: Control, SDS-PAGE, WB
• Species Reactivity: Human
• Conjugation: Unconjugated
• Alternative Names: C17orf92, Prostate,Rectum And Colon, Small nuclear protein PRAC1, Prostate cancer susceptibility candidate protein 1, Prostate, rectum and colon expressed gene protein

Product Description

Recombinant Human Prostate Cancer Susceptibility Candidate (PRAC) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Prostate Cancer

Product Properties

• Molecular Weight: 36kDa
• Tag: N-terminal His and GST Tag
• NCBI: 84366
• Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Purity: >90% by SDS-PAGE
• Form: Freeze-Dried Powder
• Target: Prostate Cancer Susceptibility Candidate (PRAC)